Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate vs Visudyne in Wet AMD
NCT00041483Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2002
- Primary completion
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anecortave in exudative macular degeneration, sponsored by Alcon Inc.. Started Jun 2002; status: completed.
02
Drugs
anecortave
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT00041483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041483.